Core Viewpoint - The stock price of Pomegranate Cloud Medical (POM.US) declined by 3.72% after its IPO, despite an initial surge of nearly 25% on its debut day [1] Company Summary - Pomegranate Cloud Medical went public on the NASDAQ on October 8, 2023, with an IPO price of $4 per American Depositary Share (ADS), which is at the lower end of the expected range of $4 to $6 [1] - The IPO raised a total of $20 million by issuing 5 million ADS [1] - As of December 31, 2024, the company has signed contracts with over 212,800 doctors and has issued more than 3 million prescriptions [1] - The company has a patient base of 699,000 who have engaged in service consumption [1] Industry Summary - The online chronic disease management service sector is seeing increased interest, as evidenced by the IPO activity of Pomegranate Cloud Medical [1] - The performance of Pomegranate Cloud Medical's stock post-IPO may reflect broader market sentiments towards healthcare technology companies [1]
美股异动 | 石榴云医(POM.US)夜盘跌近4% 纳斯达克首秀收涨0.75%